ACH
Accendra Health, Inc.
NYSE · Healthcare · Medical - Distribution · US
$1.21
−0.82%Aug 17, 2026, 10:30 UTC
Accendra Health announced it will not implement an at-the-market equity issuance program due to recent market conditions, abandoning the plan to issue modest amounts of equity over time to reduce debt.
Source:Aug 10, 2026, 10:50 UTC
Accendra Health's Board of Directors adopted a Section 382 Rights Agreement (Tax Asset Preservation Plan) to protect its net operating loss carryforwards and other tax attributes, announced on August 10, 2026.
Source:Aug 10, 2026, 10:45 UTC
Accendra Health reported its financial results for the second quarter ended June 30, 2026, reflecting continuing operations from its Patient Direct segment.
Source:Jun 15, 2026, 00:00 UTC
Accendra Health Inc amended its existing 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030, eliminating substantially all affirmative and negative covenants and certain events of default, effective June 15, 2026 after receiving sufficient note holder consents.
Jun 14, 2026, 05:57 UTC
Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) acquires an additional 12% stake in Arabian Medical Products Manufacturing Co. (ENAYAH) from Accendra Health, Inc., increasing its ownership from 51% to 63%.
Source:Jun 10, 2026, 10:30 UTC
Accendra Health announced early results of offers to exchange its 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030.